Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

A decades-long study of Danish conscripts finds that despite the rise in obesity, the inverse relationship between intelligence and BMI has remained unchanged.

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...

The Philadelphia Eagles won Super Bowl LIX on Sunday, defeating the Kansas City 40-22. The 2025 Super Bowl commercial lineup ...

Appalachia has a rich history and gorgeous landscapes, but it has also experienced rates of cancer incidence and death ...

Community advocate Dave Letele – whose latest TV show screens on Thursday highlighting New Zealand’s obesity epidemic – is ...

Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.

Community advocate Dave Letele – whose latest TV show screens on Thursday highlighting New Zealand’s obesity epidemic – is ...

Several small biotechs working on new treatments for weight loss believe that developing therapies with mechanism of actions not seen with current drugs, such as those from Novo Nordisk (NVO) and Eli ...

ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...

Surrogate measures of insulin resistance, based on the triglyceride-glucose index, can be used to predict the development of ...